Log In
Print this Print this

Phosribbon (Z-521)

  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionPhosphate replacement therapy
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat hypophosphatemia; Treat hypophosphatemic rickets
Regulatory Designation Japan - Orphan Drug (Treat hypophosphatemic rickets)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today